Chemokines in human breast tumor cells: modifying their expression levels and determining their effects on the malignancy phenotype.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Methods in Enzymology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0076-6879(09)05201-XPMID 19446718
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages.

  2008cited by this paper
• The role of CXC chemokines and their receptors in cancer.

  2008cited by this paper
• The inflammatory chemokines CCL2 and CCL5 in breast cancer.

  2008cited by this paper
• Organ selectivity in metastasis: regulation by chemokines and their receptors

  2007cited by this paper
• Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

  2007cited by this paper
• The chemokine and chemokine receptor superfamilies and their molecular evolution

  2006cited by this paper
• The multifaceted roles of chemokines in malignancy

  2006influential reference
• Cancer CXC chemokine networks and tumour angiogenesis.

  2006cited by this paper
• Supplemental Data Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion

  2005cited by this paper
• Role of Chemokines in Angiogenesis: CXCL12/SDF‐1 and CXCR4 Interaction, a Key Regulator of Endothelial Cell Responses

  2003cited by this paper
• Effect of Matrigel on the tumorigenicity of human breast and ovarian carcinoma cell lines.

  1996cited by this paper
• Effect of matrigel on the tumorigenicity of human breast and ovarian carcinoma cell lines

  1996cited by this paper

• Blocking lactate export by inhibiting the Myc target MCT1 Disables glycolysis and glutathione synthesis.

  2014cites this paper
• Mechanisms regulating the secretion of the promalignancy chemokine CCL5 by breast tumor cells: CCL5's 40s loop and intracellular glycosaminoglycans.

  2012influential citation
• High expression of CX3CL1 by tumor cells correlates with a good prognosis and increased tumor‐infiltrating CD8+ T cells, natural killer cells, and dendritic cells in breast carcinoma

  2012cites this paper